A beneficial role of cardiac P2X 4 receptors in heart failure: Rescue of the calsequestrin overexpression model of cardiomyopathy

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 287, Issue 3 56-3, 2004, Pages

  Yang, Alexander ^a   Sonin, Dimitry ^a   Jones, Larry ^b   Barry, William H ^c   Liang, Bruce T ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Adenine nucleotide; Cardiac failure; Contraction; Isoproterenol; Purines

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE TRIPHOSPHATE; CALCIUM ION; CALSEQUESTRIN; ION CHANNEL; ISOPRENALINE; LIGAND; PURINE DERIVATIVE; PURINE P2X4 RECEPTOR;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CARDIOMYOPATHY; CHANNEL GATING; CONTROLLED STUDY; DEATH; DISEASE COURSE; DOG; GENE OVEREXPRESSION; GENETIC CROSS; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTILITY; HEART PERFORMANCE; HUMAN; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SURVIVAL TIME; TRANSGENIC MOUSE;

ANIMALS; CALSEQUESTRIN; CARDIAC OUTPUT, LOW; CARDIOMYOPATHIES; DOGS; HEART; HUMANS; LONGEVITY; MICE; MYOCARDIAL CONTRACTION; MYOCARDIUM; RECEPTORS, PURINERGIC P2; RECOVERY OF FUNCTION; TIME FACTORS;

EID: 4143150614     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00079.2004     Document Type: Article

References (25)

1. Barkalow K and Hartwig JH. Actin cytoskeleton. Setting the pace of cell movement. Curr Biol 5: 1000-1002, 1995.
2. Cho MC, Rapacciuolo A, Koch WJ, Kobayashi Y, Jones LR, and Rockman HA. Defective beta-adrenergic receptor signaling precedes the development of dilated cardiomyopathy in transgenic mice with calsequestrin overexpression. J Biol Chem 274: 22251-22256, 1999.
3. 2+ concentration in isolated rat ventricular myocytes. J Physiol 445: 369-388, 1992.
4. Danziger RS, Raffaeli S, Moreno-Sanchez R, Sakai M, Capogrossi MC, Spurgeon HA, Hansford RG, and Lakatta EG. Extracellular ATP has a potent effect to enhance cytosolic calcium and contractility in single ventricular myocytes. Cell Calcium 9: 193-199, 1988.
5. 2+ transients in cardiac myocytes. Am J Physiol Cell Physiol 257: C750-C758, 1989.
6. Fredholm BB, Abbracchio MP, Burnstock G, Dubyak GR, Harden TK, Jacobson KA, Schwabe U, and Williams M. Towards a revised nomenclature for P1 and P2 receptors. Trends Pharmacol Sci 18: 79-82, 1997.
7. Gotzmann J and Gerner C. A method to produce Ponceau replicas from blotts: application for Western analysis. Electrophoresis 21: 523-525, 2000.
8. Harding VB, Jones LR, Lefkowitz RJ, Koch WJ, and Rockman HA. Cardiac βARK1 inhibition prolongs survival and augments β-blocker therapy in a mouse model of severe heart failure. Proc Natl Acad Sci USA 98: 5809-5814, 2001.
9. 4 receptor transgenic mouse. FASEB J 15: 2739-2741, 2001.
10. 4 receptor is a glycosylated cardiac receptor mediating a positive inotropic response to ATP. J Biol Chem 277: 15752-15757, 2002.
11. 2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin. J Clin Invest 101: 1385-1393, 1998.
12. Khakh BS, Burnstock G, Kennedy C, King BF, North RA, Seguela P, Voigt M, and Humphrey PA. International union of pharmacology XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev 53: 107-118, 2001.
13. Kirchhefer U, Neumann J, Baba HA, Begrow F, Kobayashi YM, Trinke U, Schmitz W, and Jones LR. Cardiac hypertrophy and impaired relaxation in transgenic mice overexpressing triadin 1. J Biol Chem 276: 4142-4149, 2001.
14. Klein D, Kern RM, and Sokol RZ. A method for quantification and correction of proteins after transfer to immobilization membranes. Biochem Mol Biol Int 36: 59-66, 1995.
15. Le KT, Villeneuve P, Ramjaun AR, McPherson PS, Beaudet A, and Seguela P. Sensory presynaptic and widespead somatodendritic immunolocalization of central ionotropic P2X ATP receptors. Neuroscience 83: 177-190, 1998.
16. Maccioni RB and Cambiazo V. Role of microtubule-associated proteins in the control of microtubule assembly. Physiol Rev 75: 835-864, 1995.
17. Mei Q and Liang BT. P2 purinergic receptor activation enhances cardiac contractility in isolated rat and mouse hearts. Am J Physiol Heart Circ Physiol 281: H334-H341, 2001.
18. Ralevic V and Burnstock G. Roles of P2-purinoceptors in the cardiovascular system. Circulation 84: 1-14, 1991.
19. Ralevic V and Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 50: 413-492, 1998.
20. Rubio ME and Soto F. Distinct localization of P2X receptors at excitatory postsynaptic specializations. J Neurosci 21: 641-653, 2001.
21. Sato Y, Ferguson DG, Sako H, Dorn IIGW, Kadambi VJ, Yatani A, Hoit BD, Walsh RA, and Kranias EG. Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice. J Biol Chem 273: 28470-28477, 1998.
22. Sato Y, Kiriazis H, Yatani A, Schmidt AG, Hahn H, Ferguson DG, Sako H, Mitarai S, Honda R, Mesnard-Rouiller L, Frank KF, Beyermann B, Wu G, Fujimori K, Dorn IIGW, and Kranias EG. Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation. J Biol Chem 276: 9392-9399, 2001.
23. Scamps F, Legssyer A, Mayoux E, and Vassort G. The mechanism of positive inotropy induced by adenosine triphosphate in rat heart. Circ Res 67: 1007-1016, 1990.
24. Soto F, Garcia-Guzman M, and Stuhmer W. Cloned ligand-gated channels activated by extracellular ATP (P2X receptors). J Membr Biol 160: 91-100, 1997.
25. Zhu MY, Klimek V, Haycock JW, and Ordway GA. Quantitation of tyrosine hydroxylase protein in the locus coeruleus from postmortem human brain. J Neurosci Methods 99: 37-44, 2000.